H-SL^YNTVATL-OH

Ref. 3D-PP41703

Produktinformation

• Name: H-SL^YNTVATL-OH

Beschreibung

Peptide H-SL^YNTVATL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SL^YNTVATL-OH include the following: Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. TJ Tsomides, A Aldovini , RP Johnson - The Journal of , 1994 - rupress.orghttps://rupress.org/jem/article-abstract/180/4/1283/25381 Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual T Harrer, E Harrer, P Barbosa, F Kaufmann - The Journal of , 1998 - journals.aai.orghttps://journals.aai.org/jimmunol/article/161/9/4875/31899 Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance S Tenzer , E Wee, A Burgevin, G Stewart-Jones - Nature , 2009 - nature.comhttps://www.nature.com/articles/ni.1728 Amino acid similarity accounts for T cell cross-reactivity and for"holes" in the T cell repertoire S Frankild, RJ De Boer , O Lund , M Nielsen , C Kesmir - PloS one, 2008 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001831 Theoretical Dynamics and Energetics of HLA-A2/SLYNTVATL Interaction O Olaposi, H Tsuyoshi - American Journal of Bioinformatics Research, 2015 - academia.eduhttps://www.academia.edu/download/70861651/10.5923.j.bioinformatics.20150501.01.pdf MHC Class I Molecules with NA CTLs, SCD Binding - J. Immunol, 2010 - Citeseerhttps://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=f8202eb4619e178604accb92076d32557c5daa64 MHC Class I Molecules with Superenhanced NA CTLs - 2010 - researchgate.nethttps://www.researchgate.net/profile/Rachel-Hewitt-6/publication/41622720_MHC_Class_I_Molecules_with_Superenhanced_CD8_Binding_Properties_Bypass_the_Requirement_for_Cognate_TCR_Recognition_and_Nonspecifically_Activate_CTLs/links/0c9605208d6e41f38a000000/MHC-Class-I-Molecules-with-Superenhanced-CD8-Binding-Properties-Bypass-the-Requirement-for-Cognate-TCR-Recognition-and-Nonspecifically-Activate-CTLs.pdf Accurate structure prediction of peptide-MHC complexes for identifying highly immunogenic antigens MS Park, SY Park, KR Miller, EJ Collins, HY Lee - Molecular immunology, 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0161589013001545 Suboptimal stimulation by weak agonist epitope variants does not drive dysfunction of HIV-1-specific cytotoxic T lymphocyte clones MA Grossman , C Hofmann , HL Ng, OO Yang - AIDS, 2019 - journals.lww.comhttps://journals.lww.com/aidsonline/FullText/2019/08010/Suboptimal_stimulation_by_weak_agonist_epitope.3.aspx Competition among peptides in melanoma vaccines for binding to MHC molecules LW Thompson, CF Garbee, S Hibbitts - Journal of , 2004 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2004/11000/competition_among_peptides_in_melanoma_vaccines.2.aspx T cell cross-reactivity and conformational changes during TCR engagement JK Lee, G Stewart-Jones, T Dong , K Harlos - The Journal of , 2004 - rupress.orghttps://rupress.org/jem/article-abstract/200/11/1455/54291 Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent JA Whelan, P Dunbar , DA Price - The Journal of , 1999 - journals.aai.orghttps://journals.aai.org/jimmunol/article/163/8/4342/32436 The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope J Kan-Mitchell, B Bisikirska , F Wong-Staal - The Journal of , 2004 - journals.aai.orghttps://journals.aai.org/jimmunol/article/172/9/5249/72181 Peptides for vaccine development IW Hamley - ACS Applied Bio Materials, 2022 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsabm.1c01238 Characterization of MHC ligands for peptide based tumor vaccination F Klug, M Miller, HH Schmidt - Current pharmaceutical , 2009 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cpd/2009/00000015/00000028/art00003 Structural basis for degenerate recognition of natural HIV peptide variants by cytotoxic lymphocytes E Martinez-Hackert , N Anikeeva , SA Kalams - Journal of biological , 2006 - ASBMBhttps://www.jbc.org/article/S0021-9258(19)76335-2/abstract Dual molecular mechanisms govern escape at immunodominant HLA A2-restricted HIV epitope DK Cole , A Fuller, G Dolton , E Zervoudi - Frontiers in , 2017 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2017.01503/full Antigen-specific release of beta-chemokines by anti-HIV-1 cytotoxic T lymphocytes DA Price, AK Sewell , T Dong , R Tan , PJR Goulder - Current biology, 1998 - cell.comhttps://www.cell.com/current-biology/pdf/S0960-9822(98)70138-1.pdf A mAb against HLA-A2 can be influenced both positively and negatively by the associated peptide D Barouch , M Davenport , A McMichael - International , 1995 - academic.oup.comhttps://academic.oup.com/intimm/article-abstract/7/10/1599/714190 High responsiveness of HLA-B57-restricted Gag-specific CD8+ T cells in vitro may contribute to the protective effect of HLA-B57 in HIV-infection CA Jansen, S Kostense - European journal of , 2005 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200425487 Random screening of proteins for HLA-A* 0201-binding nine-amino acid peptides is not sufficient for identifying CD8 T cell epitopes recognized in the context of HLA C Pelte, G Cherepnev, Y Wang - The Journal of , 2004 - journals.aai.orghttps://journals.aai.org/jimmunol/article/172/11/6783/80929 Discovery and characterization of highly immunogenic and broadly recognized mimics of the HIV-1 CTL epitope Gag77-85 C Boggiano , R Moya, C Pinilla , F Bihl - European journal of , 2005 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200425903 Recognition of Two Overlapping CTL BD Walker , MF Kalden, RP Johnson, S Buchbinder - J Immunol, 1998 - academia.eduhttps://www.academia.edu/download/38282868/4875.pdf Conflicting selective forces affect T cell receptor contacts in an immunodominant human immunodeficiency virus epitope AKN Iversen, G Stewart-Jones, GH Learn - Nature , 2006 - nature.comhttps://www.nature.com/articles/ni1298 Antagonism of cytotoxic T lymphocyte-mediated lysis by natural HIV-1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides AK Sewell , GC Harcourt, PJR Goulder - European journal of , 1997 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.1830270929 Differential processing of HLA A2-restricted HIV type 1 cytotoxic T lymphocyte epitopes AK Sewell , BL Booth Jr, V Cerundolo, RE Phillips - Viral , 2002 - liebertpub.comhttps://www.liebertpub.com/doi/abs/10.1089/088282402317340332 Cross-reactivity between influenza matrix-and HIV-1 P17-specific CTL-a large cohort study AG Huckelhoven, JK Etschel, S Bergmann - JAIDS Journal of , 2015 - journals.lww.comhttps://journals.lww.com/jaids/fulltext/2015/08150/cross_reactivity_between_influenza_matrix__and.3.aspx Receptor Binding by Cholera Toxin B-Subunit and Amino Acid Modification Improves Minimal Peptide Immunogenicity A Boberg, A Staca¥lnacke, A Braca¥ve - International , 2012 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.5402/2012/170676

• Marke: Biosynth